At a glance
- Originator GlaxoSmithKline
- Class Antimalarials; Antiprotozoals
- Mechanism of Action Electron transport complex I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Malaria; Pneumocystis pneumonia; Toxoplasmosis
Most Recent Events
- 29 Nov 2000 Discontinued-Preclinical for Malaria in United Kingdom (Unknown route)
- 29 Nov 2000 Discontinued-Preclinical for Pneumocystis pneumonia in United Kingdom (Unknown route)
- 29 Nov 2000 Discontinued-Preclinical for Toxoplasmosis in United Kingdom (Unknown route)